Approval was based on the pivotal Phase 3 CodeBreaK 300 study.

Designed to increase throughput, decrease COGS, and reduce batch failures.

Ravensburg, January 14, 2025: Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has ...

Caris Life Sciences, a provider of molecular profiling and artificial intelligence (AI)-driven solutions for cancer treatment ...

Under the agreement, AGC Biologics will manufacture the lentiviral vector used to produce lete-cel, an engineered T-cell ...

The treatment will be stockpiled and available for rapid deployment as part of the SNS CHEMPACK program.

CGMP cytokines now available for Charles River’s Cell Therapy Flex Platform.

Emmes Group, a specialty tech and AI-enabled global contract research organization (CRO), has appointed Germaine Gross as ...

IDT Biologika, a global contract development and manufacturing organization (CDMO), has appointed Federico Pollano as Chief ...

Lyndra Therapeutics, a clinical-stage biopharmaceutical company, has entered a strategic collaboration with Thermo Fisher ...

Will integrate Cytiva's manufacturing technologies with Cellular Origins’ robotic manufacturing platform.

Piramal Pharma Limited has achieved an environmental milestone at its API and intermediates manufacturing facility in Digwal, ...